Nicholas O. Iannotti
Nicholas O. Iannotti publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Cancer Treatment and Pharmacology.
- World rank
- #269,664 of 7,710,434 ranked researchers
- Rank in United States
- #98,612 of 1,627,098
- Works
- 129
- Citations
- 7.3k
- Citations per work
- 57.0
What does Nicholas O. Iannotti research?
Nicholas O. Iannotti's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8565.9%
- Medicine8565.9%
- Everything else2217.3%
- Life Sciences2216.8%
- 1Oncology41% of their works
- 2Pulmonary and Respiratory Medicine21% of their works
- 3Immunology7% of their works
- 4Molecular Biology6% of their works
- 5Cancer Research4% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
Which keywords describe Nicholas O. Iannotti's research?
The keywords of their largest research topics: Clinical Trials, Chemotherapy, Targeted Therapy, Metastatic Breast Cancer, Genomic Profiling, Immune Checkpoint Blockade, PD-1 and PD-L1 and Breast Cancer.
- Prostate Cancer
- Trastuzumab
- HER2
- Palbociclib
- KRAS Mutations
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- EGFR Mutations
- Breast Cancer
- Immune Checkpoint Blockade
- Metastatic Breast Cancer
- Chemotherapy
- Clinical Trials
- Targeted Therapy
- Genomic Profiling
- PD-1 and PD-L1
- ALK Inhibitors
- Biomarkers
- Immunotherapy
- Cetuximab
- CDK4/6 Inhibitors
- Genomic Profiles
- Small-Cell Lung Cancer
- Androgen Receptor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Clinical Trials373 topics
- Chemotherapy333 topics
- Targeted Therapy302 topics
- Metastatic Breast Cancer282 topics
- Genomic Profiling272 topics
- Immune Checkpoint Blockade231 topic
- PD-1 and PD-L1231 topic
- Breast Cancer212 topics
- ALK Inhibitors201 topic
- EGFR Mutations201 topic
- Biomarkers172 topics
- Chemotherapy-Induced Peripheral Neuropathy171 topic
- Immunotherapy172 topics
- Taxanes171 topic
- Cetuximab131 topic
- KRAS Mutations131 topic
- CDK4/6 Inhibitors111 topic
- Palbociclib111 topic
- Genomic Profiles101 topic
- HER2101 topic
- Small-Cell Lung Cancer101 topic
- Trastuzumab101 topic
- Androgen Receptor71 topic
- Prostate Cancer71 topic
Where does Nicholas O. Iannotti work?
Nicholas O. Iannotti's main affiliation in the publication record is Hematology Oncology Associates, United States.
How many publications and citations does Nicholas O. Iannotti have?
OpenAlex counts 129 works and 7,348 citations for Nicholas O. Iannotti, an h-index of 26, ranking #269,664 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nicholas O. Iannotti. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.